Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

The Oncotype DX Recurrence Score (RS), Prosigna Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) are used clinically for estimating risk of distant recurrence for patients receiving endocrine therapy. Discordances in estimates occ...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Buus, Richard, Sestak, Ivana, Kronenwett, Ralf, Ferree, Sean, Schnabel, Catherine A., Baehner, Frederick L., Mallon, Elizabeth A., Cuzick, Jack, Dowsett, Mitch
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2021
Sujets:
ORIGINAL REPORTS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078458/
https://ncbi.nlm.nih.gov/pubmed/33108242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00853
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires